[
  {
    "ts": null,
    "headline": "ResMed Inc. stock rises Wednesday, outperforms market",
    "summary": "ResMed Inc. stock rises Wednesday, outperforms market",
    "url": "https://finnhub.io/api/news?id=200d250fdd45f9d062c4a32715000903a6d9bfb8f18803b9f2f70b07cc6a73bc",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755708720,
      "headline": "ResMed Inc. stock rises Wednesday, outperforms market",
      "id": 136461750,
      "image": "",
      "related": "RMD",
      "source": "MarketWatch",
      "summary": "ResMed Inc. stock rises Wednesday, outperforms market",
      "url": "https://finnhub.io/api/news?id=200d250fdd45f9d062c4a32715000903a6d9bfb8f18803b9f2f70b07cc6a73bc"
    }
  },
  {
    "ts": null,
    "headline": "1 Healthcare Stock Worth Investigating and 2 Facing Challenges",
    "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 7.1%. This drawdown is a far cry from the S&P 500’s 4.7% ascent.",
    "url": "https://finnhub.io/api/news?id=0f1e3a3424b1f5d244a531057713e4d430cb1a625a7101655c89b358089ea82a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755664393,
      "headline": "1 Healthcare Stock Worth Investigating and 2 Facing Challenges",
      "id": 136437934,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 7.1%. This drawdown is a far cry from the S&P 500’s 4.7% ascent.",
      "url": "https://finnhub.io/api/news?id=0f1e3a3424b1f5d244a531057713e4d430cb1a625a7101655c89b358089ea82a"
    }
  }
]